|
⚲
|
| Keyboard |
| Royston Aaron
✚
|
|
|---|---|
| CIK # | 0001727703 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727703] | |
| 4 | [0001727703] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ventyx Biosciences Inc VTYX
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 13,301 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2022-05-25 | Sell | 702,737 | $4.12 | 2,895,276 |
|
Ventyx Biosciences Inc VTYX
Common Stock
|
2021-10-25 | Conversion | 3,684,769 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Series B Preferred Stock · derivative
|
2021-10-25 | Conversion | 395,027 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Series A Preferred Stock · derivative
|
2021-10-25 | Conversion | 3,289,742 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Common Stock
|
2021-10-25 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Elevation Oncology Inc ELEV
Series B Preferred Stock · derivative
|
2021-06-29 | Conversion | 8,380,034 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Buy | 625,000 | $16.00 | 10,000,000 |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Conversion | 1,983,167 | ||
|
VYNE Therapeutics Inc MNLO
Stock Option · derivative
|
2019-06-25 | Grant | 22,500 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Series A Preferred Stock · derivative
|
2019-06-24 | Conversion | 10,666,667 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Series B Preferred Stock · derivative
|
2019-06-24 | Conversion | 722,737 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Conversion | 3,469,759 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Buy | 250,000 | $16.00 | 4,000,000 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Conversion | 235,099 |